Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0LC7 stock hub

LON/0LC7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0LC7is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9K

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0LC7

In the news

Latest news · LON/0LC7

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-777

P25 n/aP50 n/aP75 n/a

ROIC-94.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0LC7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	68
Employees Change	-49%
Employees Change Percent	-41.88
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	US87184Q2066
Last refreshed	2026-05-10
Market cap	$3,938
Price	$0
Price currency	USD
Rev Per Employee	4,235.22x
Sic	2836
Symbol	lon/0LC7
Website	https://www.syros.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,853,219.16%
FCF yield	-1,895,639.63%
P/B ratio	-0x
P/S ratio	0.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-65.8M
Net Income	$-73M
Pretax Margin	-25,340.64%
Profit Per Employee	$-1.1M
ROA	-59.88
Roa5y	-34.56
ROCE	-197
ROE	-777
Roe5y	-122
ROIC	-94.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-99.49%
Cagr3y	-96.02%
Cagr5y	-91.85%
Revenue Growth	-95.61x
Revenue Growth3 Y	-73.77x
Revenue Growth5 Y	-30.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$63.4M
Cash	$43.5M
Current Assets	$46.9M
Current Liabilities	$20.8M
Debt	$44.9M
Debt FCF	$-0.6
Equity	$-8.3M
Interest Coverage	-20.92
Liabilities	$71.7M
Long Term Assets	$16.5M
Long Term Liabilities	$50.9M
Net Cash	$-1.5M
Net Cash By Market Cap	$-36,964
Tangible Book Value	$-8.3M
Tangible Book Value Per Share	$-0.31
WACC	6.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.25
Net Working Capital	$-15M
Quick ratio	2.05
Working Capital	$26.5M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-99.48%
200-day SMA	0
3Y total return	-99.99%
50-day SMA	0
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	151.9
All Time High Change	-100%
All Time High Date	2021-01-20
All Time Low	0
All Time Low Change	100%
All Time Low Date	2025-09-23
ATR	0
Beta	1.26
High	0
High52	0.04
High52 Date	2025-05-13
High52ch	-99.5%
Low	0
Low52	0
Low52 Date	2025-10-02
Low52ch	100%
Ma50ch	-33.33%
Price vs 200-day SMA	-90.48%
RSI	46.84
RSI Monthly	24.29
RSI Weekly	29.63
Sharpe ratio	1.63x
Sortino ratio	20.75
Total Return	-31.77%
Tr3m	-75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-83.2M
Operating margin	-28,891.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,817,790%
Net Borrowing	-2,200.5
Shares Insiders	0.05%
Shares Institutions	1.99%
Shares Qo Q	0.17%
Short Ratio	2.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-80.1M
Average Volume	1,535.55x
Bv Per Share	-0.31
CAPEX	$-28,352
Ch1y	-99.48
Ch3m	-75
Ch3y	-99.99
Ch5y	-100
Ch6m	-60
Change	-50%
Change From Open	0
Close	0
Days Gap	-50
Depreciation Amortization	984,375.8
Dollar Volume	0.12
Earnings Date	2026-03-02
EBIT	$-83.2M
EBITDA	$-82.2M
EPS	$-1.98
F Score	0
FCF	$-74.7M
Financing CF	32,198,692
Fiscal Year End	December
Founded	2,011
Investing CF	1,454,149
Is Primary Listing	0
Last Earnings Date	2026-03-02
Last Report Date	2024-09-30
Last Split Date	2022-09-19
Last Split Type	Reverse
Ma150	0
Ma150ch	-71.43%
Ma20	0
Ma20ch	0%
Net CF	-40,969,097
Open	0
Ppne	12,894,442.6
Price Date	2026-05-08
Relative Volume	0.4x
Revenue	287,995x
SBC By Revenue	1,878.49x
Share Based Comp	5,409,971
Tr6m	-60%
Volume	616
Z Score	-15.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0LC7 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0LC7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0LC7?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0LC7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.8

Neutral momentum band

Price vs 200-day MA

-90.5%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

1.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0LC7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0LC7 stock rating?

lon/0LC7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0LC7 analysis?

The full report lives at /stocks/lon/0LC7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0LC7?

The latest report frames lon/0LC7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0LC7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.